OR WAIT null SECS
October 14, 2021
Aceto will acquire A&C Bio Buffer, including the company’s custom buffer and chemical blend portfolio.
Avid Bioservices is building a viral vector development and manufacturing facility near its existing biologics manufacturing facility in California.
September 14, 2021
AGC Biologics is expanding manufacturing capacity at its Heidelberg, Germany, facility for plasmid DNA and messenger RNA.
September 02, 2021
Febles will oversee day-to-day aseptic manufacturing at Pharmaceutics International, Inc.
September 01, 2021
Quotient Sciences is investing £6.3 million ($8.68 million) into their drug substance manufacturing capabilities.
August 25, 2021
AGC Biologics has broken ground on a new multipurpose facility in Copenhagen, Denmark, that will increase capacity.
Lonza plans to establish drug product manufacturing capabilities at is site in Guangzhou, China, to produce clinical trial and commercial supply in the country.
August 19, 2021
Curia plans to expand the site’s commercial capabilities with this move.
August 17, 2021
Biotage’s new facility in Cardiff, UK, will produce lipids using large-scale flash purification.
August 13, 2021
Almac Sciences has signed a manufacturing agreement with Pila Pharma for the production of the API XEN-D0501.